admin

Stereotypically, the concept of bidding up publicly traded enterprises based on their environmental, social, and governance scores – the so-called ESG stocks – might seem an extremely risky proposition. That’s because we have this idea that doing good involves sacrificing capitalistic intent like achieving profitability. To some extent, it’s a reasonable assumption. After all, true
0 Comments
Source: Robert Way / Shutterstock.com Nio (NYSE:NIO) is facing rapidly increasing competition. Meanwhile, the company’s margins are also being pressured by an accelerating price war in the Chinese electric vehicle (EV) market. But that’s not all. Nio’s addressable market is quite limited and the firm lacks strong competitive advantages. Given all of these points, I
0 Comments
The tech space is littered with casualties of the post-pandemic consolidation, but careful investors can pick through the rubble to get some of the best long-term tech stocks at reasonable prices. The industry tends to come with higher-than-normal valuations, because investors expect exponential growth. It’s a rapidly changing landscape, and companies that ride the wave of the
0 Comments
Loyal investors of electric vehicle (EV) manufacturer Lucid Group (NASDAQ:LCID) have already been through the wringer. Yet, it’s probably only going to get worse for LCID stock. As we’ll see, May 8 will be an important, and possibly terrible, day for Lucid Group and its stakeholders. Moreover, competition from the likes of Tesla (NASDAQ:TSLA) will only
0 Comments
Low-priced stocks are attractive in the sense that it allows investors to build a diversified portfolio even with a small capital. It’s also untrue that low price stocks are purely speculative. With careful screening, investors can find dozens of stocks under $10 with sound fundamentals. An added attraction is when low-priced stocks represent companies that
0 Comments
Personalized medicine stocks are hot right now. This form of medicine based on the particular genes, proteins, and other substances in a person’s body.  It promises to revolutionize healthcare making stocks in companies offering this form of medicine very intriguing.  The potential return on such shares is clearly high: Developing these treatments requires massive investments
0 Comments
Investors have shown keen interest in biotech after Johnson & Johnson’s (NYSE:JNJ) impressive earnings beat that topped Wall Street’s expectations. The earnings beat reignited enthusiasm for biotech stocks, prompting investors to search for the next big players. The pharmaceutical giant’s adjusted earnings and revenue beat expectations, with strength reported in units including pharmaceuticals. J&J also
0 Comments
If you’re looking for the best closed-end funds (CEFs) to buy, it helps if you understand what they are and aren’t. They are similar to initial public offerings (IPOs) in that an amount of capital is raised at the launch. The portfolio managers responsible for the closed-end fund then invest the funds.  CEFs resemble an investment
0 Comments
Some companies are in rapidly-growing sectors, have powerful brands, with significant moats. Indeed, such companies are often known as blue-chip stocks that will never go out of style. There are many factors that render these timeless blue-chip stocks largely impervious to competition. For one, the tremendous power of their brands and the high barriers to entry in
0 Comments
A Security Solutions Maker With Market Buzz and a Beverage Company With Momentum. Visit our website: https://www.zacks.com Visit our Stocktwits account: https://stocktwits.com/ZacksResearch Check out our weekly promotion: https://www.zacks.com/promo If you’re interested in our services, please check out Zacks Ultimate: https://www.zacks.com/ultimate/?adid=YOUTUBE&cid=sm-YOUTUBE
0 Comments
While innovative enterprises offer significant upside potential, their price point often deters would-be investors, which is what makes these tech stocks to buy near 52-week lows so attractive. Because of broader economic pressures stemming from 2022’s headwinds, several tech firms suffered sharp losses. However, a select few might make for compelling contrarian opportunities. In addition
0 Comments